Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2019The Indian Journal of Medical ResearchOpen Access

Efflux pump inhibitors for bacterial pathogens

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAtin SharmaUmeå UniversityVGVivek GuptaDeakin UniversityRPRanjana PathaniaIndian Institute of Technology Roorkee

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sharma et al. (2019) studied this question.

synapsesocial.com/papers/69d7d8d55c3030ff03d17dachttps://doi.org/10.4103/ijmr.ijmr_2079_17
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenes2002 · 157 citations
  2. 2Inhibitors of Multidrug Resistant Efflux Systems in Bacteria2009 · 172 citations
  3. 3Modulation of drug resistance in staphylococcus aureus by a kaempferol glycoside from herissantia tiubae (malvaceae)2009 · 92 citations
  4. 4Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump2015 · 35 citations